Color Genomics
Population genomics platform for employers and health systems offering hereditary cancer risk, pharmacogenomics, and genetic screening.
What it does
Color is a population genomics platform delivering genetic screening programs at scale for employers, health systems, and public health agencies. Its platform covers hereditary cancer risk assessment (BRCA1/2, Lynch syndrome), pharmacogenomics (how genes affect drug metabolism), carrier screening, and cardiac risk genetics. AI capabilities include AI-powered genetic variant interpretation applying machine learning to classify variants of uncertain significance, intelligent clinical decision support contextualizing genetic results with individual health history, and predictive risk modeling stratifying populations by genetic disease risk for proactive intervention programs. Color's employer programs have tested hundreds of thousands of employees.
Why AI-ENHANCED
Color is an established population genomics platform that has integrated AI variant interpretation, intelligent clinical decision support, and predictive risk stratification into a mature genetic screening and population health product.
Best for
Employers and health systems use Color for population genomics programs - AI-powered genetic screening identifying at-risk individuals for hereditary cancers and pharmacogenomic medication optimization.
Large employers and health plans use Color for enterprise genomic benefit programs - AI genetic risk stratification enabling proactive health interventions at population scale.
Limitations
Employer genomics programs require careful program design to ensure voluntary participation, result confidentiality from employers, and appropriate genetic counseling support.
AI variant classification for uncertain significance variants may change as scientific understanding evolves — reclassification over time is possible.
Genomic screening for conditions without clear actionable interventions has less-established benefit and should be implemented with clinical guidance.
Alternatives by segment
| If you need… | Consider instead |
|---|---|
| Precision oncology genomics | Guardant Health |
| Employee health and wellness | Spring Health |
| Population health analytics | Innovaccer |
Hereditary cancer panels from approximately $249 per person direct-to-consumer. Employer and health system programs negotiated based on population size and program scope. Annual contracts.
